Edge Therapeutics
A biotechnology company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions.
Launch date
Employees
Market cap
-
Enterprise valuation
€204—305m (Dealroom.co estimates Apr 2015.)
Berkeley Heights New Jersey (HQ)
Authorizing premium user...